A cost-effectiveness analysis of the intrapartum fetal pulse oximetry multicentre randomised controlled trial (the FOREMOST trial)

BJOG: An International Journal of Obstetrics and Gynaecology

Volumn 113, Issue 9, 2006, Pages 1080-1087

  East, C E ^a   Gascoigne, M B ^a   Doran, C M ^a   Brennecke, S P ^b   King, J F ^b   Colditz, P B ^a  

^a UNIVERSITY OF QUEENSLAND   (Australia)

^b UNIVERSITY OF MELBOURNE   (Australia)

Author keywords

Economic analysis; Fetal pulse oximetry; Randomised controlled trial

Indexed keywords

ADULT; ARTICLE; AUSTRALIA; CARDIOTOCOGRAPHY; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; COST EFFECTIVENESS ANALYSIS; FEMALE; FETAL PULSE OXIMETRY; FETUS MONITORING; HUMAN; INSTRUMENTAL DELIVERY; INTRAPARTUM CARE; MATERNITY WARD; MULTICENTER STUDY; PRIORITY JOURNAL; PULSE OXIMETRY; RANDOMIZED CONTROLLED TRIAL;

ADULT; CARDIOTOCOGRAPHY; CESAREAN SECTION; COST-BENEFIT ANALYSIS; FEMALE; FETAL DISEASES; HEART DISEASES; HEART RATE, FETAL; HUMANS; OXIMETRY; PREGNANCY; RISK FACTORS;

EID: 33748185685     PISSN: 14700328     EISSN: 14710528     Source Type: Journal    
DOI: 10.1111/j.1471-0528.2006.01044.x     Document Type: Article

References (25)

1. Umstad MP. The predictive value of abnormal fetal heart rate patterns in early labour. Aust N Z J Obstet Gynaecol 1993;33:145-9.
2. Henderson J, McCandlish R, Kumiega L, Petrou S. Systematic review of economic aspects of alternative modes of delivery. BJOG 2001;108:149-57.
3. Petrou S, Glazener C. The economic costs of alternative modes of delivery during the first two months postpartum: results from a Scottish observational study. BJOG 2002;109:214-7.
4. Laws PJ, Sullivan EA. Australia's Mothers and Babies 2002. AIHW cat no PER 28. Sydney, Australia: AIHW National Perinatal Statistics Unit (Perinatal Statistics Series No. 15), 2004.
5. Department of Health and Human Services, Centers for Disease Control and Prevention. Total and primary cesarean rate and vaginal birth after previous cesarean (VBAC) rate. United States, 1989-2003. 2005 [www.cdc.gov]. Accessed 28 February 2005.
6. National Center for Health Statistics. Peristats. 2004 [www.marchofdimes.com/peristats]. Accessed 9 December 2004.
7. East CE, Colditz PB, Begg LM, Brennecke SP. Update on intrapartum fetal pulse oximetry. Aust N Z J Obstet Gynaecol 2002;42:119-24.
8. East CE, Brennecke SP, King JF, Chan FY, Colditz PB, on behalf of the FOREMOST Study Group. The effect of intrapartum fetal pulse oximetry, in the presence of a non-reassuring fetal heart rate pattern, on operative delivery rates for non-reassuring fetal status: a multicenter, randomized controlled trial (the FOREMOST trial). Am J Obstet Gynecol 2006;194:606, e1-16.
9. Villar J, Ba'aqeel H, Piaggio G, Lumbiganon P, Miguel BJ, Farnot U, et al. WHO antenatal care randomised trial for the evaluation of a new model of routine antenatal care. Lancet 2001;357:1551-64.
10. Plunkett BA, Grobman WA. Routine hepatitis C virus screening in pregnancy: a cost-effectiveness analysis. Am J Obstet Gynecol 2005;192:1153-61.
11. Gafni A, Goeree R, Myhr TL, Hannah ME, Blackhouse G, Willan AR, et al. Induction of labour versus expectant management for prelabor rupture of the membranes at term: an economic evaluation. Can Med Assoc J 1997;157:1519-25.
12. Goeree R, Hannah M, Hewson S. Cost-effectiveness of induction of labour versus serial antenatal monitoring in the Canadian Multicentre Postterm Pregnancy Trial. Can Med Assoc J 1995;152:1445-50.
13. Macones GA, Goldie SJ, Peipert JF. Cost-effectiveness analysis: an introductory guide for clinicians. Obstet Gynecol Surv 1999;54:663-72.
14. Duckett SJ. Casemix funding for acute hospital inpatient services in Australia. Med J Aust 1998;169:S17-21.
15. Australian Bureau of Statistics. 6401.0 Consumer Price Index, Australia. Canberra, Australia: Australian Bureau of Statistics, 2004.
16. East CE, Brennecke SP, King JF, Chan FY, Colditz PB, on behalf of the FOREMOST Study Group. The FOREMOST Study 2006 [http://www.som.uq.edu.au/ research/prc/foremosttrial.asp].
17. Australian Government Department of Health and Ageing. National Hospital Cost Data Collection: Cost Report Round 7. Canberra, Australia: Commonwealth Department of Health and Ageing, 2004.
18. Australian Government Department of Health and Ageing. Schedule of Pharmaceutical Benefits. Canberra, Australia: Commonwealth of Australia, 2004.
19. Drummond MF, O'Brien BJ, Stoddart GL, Torrance GW. Cost-effectiveness analysis. In: Drummond MF, O'Brien BJ, Stoddart GL, Torrance GW, editors. Methods for the Economic Evaluation of Health Care Programmes and Edition. Oxford, UK: Oxford University Press; 1997. pp. 96-138.
20. Briggs A. Handling uncertainty in economic evaluation and presenting the results. In: Drummond MF, McGuire A, editors. Methods for the Economic Evaluation of Health Care Programmes and Edition. Oxford, UK: Oxford University Press, 2001.
21. Altman DG, Dore CJ. Randomisation and baseline comparisons in clinical trials. Lancet 1990;335:149-53.
22. Efron B, Tibshirani R. An Introduction to the Bootstrap. Monographs on statistics and applied probability, No. 57. New York: Chapman and Hall, 1993.
23. Spencer MK, MacLennan A. How long does it take to deliver a baby by emergency caesarean section? Aust N Z J Obstet Gynaecol 2001;41:7-11.
24. East CE, Brennecke SP, King JF, Chan FY., Colditz PB, on behalf of the FOREMOST Study Group. Clinicians' perceptions of placing a fetal oximetry sensor in a multicentre randomised controlled trial (the FOREMOST trial). Aust N Z J Obstet Gynaecol 2006;46:234-9.
25. East CE, Chan FY, Brennecke SP, King JF, Colditz PB., on behalf of the FOREMOST Study Group. Women's evaluations of their experience in a multicenter randomized controlled trial of intrapartum fetal pulse oximetry (the FOREMOST trial). Birth 2005;33:101-09.